Three-Drug Regimen Treats Cystic Fibrosis in Younger Children
Elexacaftor/tezacaftor/ivacaftor well tolerated in children aged 6 through 11 years with cystic fibrosis and at least one F508del-CFTR allele
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.